Last reviewed · How we verify
NCT05297097
The Impact of a Human Breast Milk Supplement on Epigenetic and Cellular Markers
Phase 2 trial testing Trulacta breastmilk supplement in Aging in 30 participants. Status unknown.
1 December 2022
Quick facts
| Lead sponsor | TruDiagnostic |
|---|---|
| Phase | Phase 2 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 30 |
| Start date | 1 March 2022 |
| Primary completion | 1 December 2022 |
| Estimated completion | 30 December 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Trulacta breastmilk supplement
Conditions studied
- Aging — all drugs for Aging →
Sponsor
TruDiagnostic — full company profile →
Who can join
Adults 18 to 85, any sex, with Aging. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a trial to assess the effects of the Trulacta supplement on biological age, sleep quality, immune system and wellness markers.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Epigenetic regulation of aging: implications for interventions of aging and diseases.
Wang K, Liu H, Hu Q, Wang L, et al · · 2022 · cited 406× · PMID 36336680 · DOI 10.1038/s41392-022-01211-8 -
Insights into the Role of Histone Methylation in Brain Aging and Potential Therapeutic Interventions.
Vitorakis N, Piperi C. · · 2023 · cited 12× · PMID 38139167 · DOI 10.3390/ijms242417339
Verify or expand the search:
- PubMed search for NCT05297097
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Aging
Currently open trials in the same condition.
- NCT02831335 — Technical Development of Multi-Parametric Renocerebral MRI · recruiting
- NCT07099053 — Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging · recruiting
- NCT07504068 — Effects of Physical Exercise and a Nutritional Supplement on Body Composition, Metabolic Function, and Overall Health in · NA · recruiting
- NCT07525453 — Effects of Three Different Exercise Programs on Dynamic Balance in Community-Dwelling Older Adults · NA · recruiting
- NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting
Other TruDiagnostic trials
Trials by the same sponsor.
- NCT05535608 — Targeting the Nine Hallmarks of Aging on DNA Methylation · Phase 2 · unknown
- NCT05294835 — Ketamine and Epigenetic Aging · Phase 2 · unknown
- NCT05297019 — A Dosing Study of Hyperbaric Oxygen Therapy (HBOT) on Epigenetic Aging · Phase 2, PHASE3 · unknown
- NCT04939155 — Methylation Effects of COV-19 Infection and Vaccinations · unknown
- NCT04946383 — Safety and Effectivness of Quercetin & Dasatinib on Epigenetic Aging · Phase 2 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05297097 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by TruDiagnostic
- Last refreshed: 8 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05297097.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing